Ironwood Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowe…

Drug Manufacturers - Specialty & Generic
US, Boston [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Ironwood Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Ironwood Pharmaceuticals, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Ironwood Pharmaceuticals, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of IRWD's Analysis
CIK: 1446847 CUSIP: 46333X108 ISIN: US46333X1081 LEI: - UEI: -
Secondary Listings
IRWD has no secondary listings inside our databases.